OR WAIT null SECS
Click here to read the articles and view the interactive digital edition
Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.
From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.
Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.
December 20, 2024
As a result, the provider increases its involvement in the country’s pharma sector.
The latest news for pharma industry insiders.
December 19, 2024
A cohort study explores the connection between the two, along with the impact of educational attainment on this relationship.
December 18, 2024
Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses observations in enterprise value growth and enterprise value-to-sales ratios among top biopharmaceutical companies.
Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.
December 17, 2024
Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses "Enhancing Patient Access and Support Through Technology: A Comprehensive Assessment," and upcoming industry challenges.
The 430,000 square-foot finished production facility will house multiple product types within the rare disease sector, including hemophilia.